DEVICES AND METHODS FOR DETECTING ANALYTE IN BODILY FLUID

• US 20130280696A1
• Filed: 03/15/2013
• Published: 10/24/2013
• Est. Priority Date: 04/23/2012
• Status: Abandoned Application

• Current Assignee: UHL II, LLC
• Original Assignee: Elliott Millenson, Wendy Strongin
• Inventors: MILLENSON, Elliott, STRONGIN, Wendy, MILLENSON, Carolyn
• Application Number:
  US13/844,712
• Publication Number:
  US 20130280696A1
• Time in Patent Office: Days
• US Class Current: 435/5
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: G01N 2333/16 HIV-1, HIV-2
• CPC Class Codes: G01N 33/54366 Apparatus specially adapted for solid-phase testing
• CPC Class Codes: G01N 33/56988 HIV or HTLV

Abstract

A test device for detecting an analyte in a sample of bodily fluid, includes at least one hollow needle configured to obtain a sample of bodily fluid, an enclosure configured to contain a reagent, a portion configured to open the enclosure, a test results indicator configured to absorb the bodily fluid, the test results indicator including at least one test zone configured to indicate the presence of an analyte in the bodily fluid when the at least one test zone is in fluidic contact with the reagent, a housing, and a cover configured to be movable with respect to the housing between a closed position precluding access to the at least one hollow needle and an open position permitting access to the at least one hollow needle. Additionally, the at least one hollow needle is in fluid communication with the test results indicator.

Claims

1. A test device for detecting an analyte in a sample of bodily fluid, comprising:

at least one hollow needle configured to obtain a sample of bodily fluid;

an enclosure configured to contain a reagent;

a portion configured to open the enclosure;

a test results indicator configured to absorb the bodily fluid, the test results indicator including at least one test zone configured to indicate the presence of an analyte in the bodily fluid when the at least one test zone is in fluidic contact with the reagent;

a housing; and

a cover configured to be movable with respect to the housing between a closed position precluding access to the at least one hollow needle and an open position permitting access to the at least one hollow needle;

wherein the at least one hollow needle is in fluid communication with the test results indicator.

2. The test device according to claim 1, wherein the test results indicator is configured to indicate the presence of HIV.

3. The test device according to claim 1, wherein the at least one hollow needle has a coating comprising an anesthetic.

4. The test device according to claim 1, wherein the at least one hollow needle has a longitudinal length equal to or less than 4 mm.

5. The test device according to claim 1, wherein the test results indicator is a first test results indicator configured to indicate the presence of a first analyte in the bodily fluid, and wherein the test device further comprises a second test results indicator configured to absorb the bodily fluid, the second test results indicator including at least one second test zone configured to indicate the presence of a second analyte in the bodily fluid when the at least one second test zone is in fluidic contact with the reagent, the second analyte differing from the first analyte;

and

wherein the first test results indicator is spaced apart from the second test results indicator.

6. The test device according to claim 5, further comprising a first fluid transport portion between the at least one hollow needle and the first test results indicator, and a second transport portion between the at least one hollow needle and the second test results indicator.

7. The test device according to claim 6, wherein the first fluid transport portion is configured to transport a larger volume of the bodily fluid than the second fluid transport portion.

8. The test device according to claim 1, wherein the cover is configured to be in the open position while the enclosure is open.

9. A test device for detecting an analyte in a sample of bodily fluid, comprising:

a sample collector defining a first volume configured to contain a sample of bodily fluid;

an enclosure configured to contain a reagent;

a portion configured to open the enclosure;

a chamber defining a fixed second volume, the chamber being configured to permit mixing of the bodily fluid and the reagent;

a test results indicator configured to absorb the bodily fluid, the test results indicator including at least one test zone configured to indicate the presence of an analyte in the bodily fluid when the at least one test zone is in fluidic contact with the reagent; and

wherein the sample collector is in fluid communication with the test results indicator such that the bodily fluid flows from the sample collector to the test results indicator; and

wherein the sample collector is configured such that the first volume remains substantially unchanged when bodily fluid flows from the sample collector to the test results indicator.

10. The test device according to claim 9, wherein the test results indicator is configured to indicate the presence of HIV.

11. The test device according to claim 9, wherein the sample collector includes at least one hollow needle.

12. The test device according to claim 11, wherein the at least one hollow needle has a longitudinal length equal to or less than 4 mm.

13. The test device according to claim 11, wherein the sample collector includes an opening defining a cavity having an interior bottom portion, the interior bottom portion including a raised section;

wherein the at least one hollow needle extends out from the bottom portion by a first height;

wherein the raised section has a second height greater than or equal to the first height; and

wherein at least a portion of the raised section is positioned between the at least one hollow needle and the opening.

14. A method for detecting an analyte in a sample of bodily fluid via a test device including

a sample collector defining a volume configured to contain a sample of bodily fluid,

an enclosure containing a reagent, and

a test results indicator configured to absorb the bodily fluid, the test results indicator including at least one test zone configured to indicate the presence of an analyte in the bodily fluid when the at least one test zone is in fluidic contact with the reagent,

wherein the method comprises:

acquiring the sample of bodily fluid with the sample collector;

conveying the bodily fluid from the sample collector;

releasing the reagent from the enclosure; and

mixing the bodily fluid with the reagent;

wherein the volume of the sample collector remains substantially unchanged during the releasing the reagent.

15. The method according to claim 14, wherein the sample collector includes at least one hollow needle;

and

wherein acquiring the sample further includes piercing tissue via the at least one hollow needle such that the sample flows through the at least one hollow needle.

16. The method according to claim 15, wherein the at least one hollow needle has a longitudinal length equal to or less than 4 mm.

17. The method according to claim 14, wherein the test device further includes a cover and a housing;

and

the method further includes locking the cover to the housing after the acquiring the sample.

18. The method according to claim 14, wherein the mixing the bodily fluid with the reagent occurs while the test device is positioned in any horizontal or vertical orientation.

19. The method according to claim 14, wherein the acquiring the sample and the releasing the reagent occur at substantially the same time.

20. The method according to claim 14, wherein the method further includes indicating the presence or absence of the analyte in the bodily fluid.